LBA36 Nivolumab (N) + ipilimumab (I) vs EXTREME as first-line (1L) treatment (tx) for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Final results of CheckMate 651
Argiris, A., Harrington, K., Tahara, M., Ferris, R.L., Gillison, M., Fayette, J., Daste, A., Koralewski, P., Mesia Nin, R., Saba, N.F., Mak, M., Álvarez Avitia, M.A., Guminski, A., Müller-Richter, U., Kiyota, N., Roberts, M., Khan, T.A., Miller-Moslin, K., Wei, L., Robert Haddad, R.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Alternating chemotherapy: Gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer
Aguilar-Ponce, J.L, Granados-García, M, Cruz López, J.C, Maldonado-Magos, F, Alvarez-Avitia, M.A, Arrieta, O, González-Ramírez, I, Lara-Cruz, G, Martinez-Juárez, I, Medina-Santillan, R, Castillo-Hernández, C, De la Garza-Salazar, J
Published in Oral oncology (01.03.2013)
Published in Oral oncology (01.03.2013)
Get full text
Journal Article
P1.15-20 Diagnosis and Treatment Delay Among Patients with Lung Cancer in Mexican Population
Macedo-Pérez, O., Talavera-Caro, F., Lyra-González, I., Campos-Peralta, K., Sobrevilla-Moreno, N., Alvarez-Avitia, M.A., Jiménez-Fuentes, E.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article